{"id":494639,"date":"2020-07-08T16:12:01","date_gmt":"2020-07-08T16:12:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=494639"},"modified":"2020-07-08T16:12:01","modified_gmt":"2020-07-08T16:12:01","slug":"global-viral-vectors-and-plasmid-dna-market-value-expected-to-reach-105-billion-by-2023","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/global-viral-vectors-and-plasmid-dna-market-value-expected-to-reach-105-billion-by-2023_494639.html","title":{"rendered":"Global Viral Vectors And Plasmid DNA Market Value Expected To Reach $1.05 Billion By 2023"},"content":{"rendered":"
MassBiologics Is One Of The Largest Players In The Viral Vectors & Plasmid DNA Market, According To The Business Research Company\u2019s Viral Vectors & Plasmid DNA Market Global Report 2020-30: COVID-19 Implications And Growth. (Companies Covered: FUJIFILM Diosynth Biotechnologies, FinVector Vision Therapies, Lonza, Cobra Biologics and Pharmaceutical Services, Brammer Bio, Cell and Gene Therapy Catapult, VGXI, MassBiologics, Sanofi)<\/div>\n

The global viral vectors & plasmid DNA market is expected to grow from $0.46 billion in 2019 to $0.60 billion in 2020 at a rate of 31.3%. The growth is mainly due to the outbreak of COVID-19 as it requires targeted delivery of the drug to treat affected patients. The number of cases has been increasing, resulting in a surge in demand for viral vectors & plasmid DNA. The market is expected to reach $1.05 billion in 2023 at a rate of about 20.4%.<\/p>\n

Read More On The Global Viral Vectors & Plasmid DNA Market Report At –<\/strong>https:\/\/www.thebusinessresearchcompany.com\/report\/viral-vectors-and-plasmid-dna-market-global-report-2020-30-covid-19-implications-and-growth<\/p>\n

<\/a><\/h4>\n

Viral vectors & plasmid DNA are used for the delivery of cellular therapies, like gene therapy and immunotherapy, and also for treating some viral infections. Viral vectors & plasmid DNA are used for formulation development in research and development labs. Viral vectors are genetically engineered viruses carrying viral RNA or DNA that is noninfectious but still contain viral promoters and transgenes. Plasmid DNA is a double-stranded extrachromosomal and circular DNA sequence that is capable of replication using the host cell’s replication system.<\/p>\n

Global Viral Vectors & Plasmid DNA Market Segmentation –<\/strong><\/p>\n

The Viral Vectors & Plasmid DNA market covered in this report is segmented –
1) By Product: Plasmid DNA, Viral Vectors
2) By Applications: Gene And Cancer Therapies, Viral Infections, Immunotherapy, Formulation Development, Others<\/p>\n

Global Viral Vectors & Plasmid DNA Market Trends – <\/strong><\/h4>\n

In January 2020, a US-based company skilled in cell and cell-mediated gene therapy products, Cognate Bioservices acquired Cobra Biologics, which is specialized in providing manufacturing services for plasmid DNA and viral vectors. The acquisition is expected to create a platform for the life cycle management of cell and gene therapy products. Cobra biologics is well established in the development and manufacture of a variety of viral vectors and DNA. The combined Cognate and Cobra expertise is expected to push both businesses to a better position to respond to current and future market demand.<\/p>\n

Request For A Sample Of The Global Viral Vectors & Plasmid DNA Market Report At –<\/strong>https:\/\/www.thebusinessresearchcompany.com\/sample.aspx?id=3245&type=smp<\/p>\n

<\/a>A Few Points From The Global Viral Vectors & Plasmid DNA Market ToC<\/strong><\/p>\n

1. Executive Summary<\/p>\n

2. Viral Vectors & Plasmid DNA Market Characteristics<\/p>\n

3. Viral Vectors & Plasmid DNA Market Size And Growth<\/p>\n

3.1. Global Viral Vectors & Plasmid DNA Historic Market, 2015 – 2019, $ Billion<\/p>\n

3.1.1. Drivers Of The Market<\/p>\n

3.1.2. Restraints On The Market<\/p>\n

3.2. Global Viral Vectors & Plasmid DNA Forecast Market, 2019 – 2023F, 2025F, 2030F, $ Billion<\/p>\n

3.2.1. Drivers Of The Market<\/p>\n

3.2.2. Restraints On the Market<\/p>\n

4. Viral Vectors & Plasmid DNA Market Segmentation<\/p>\n

5. Viral Vectors & Plasmid DNA Market Regional And Country Analysis<\/p>\n

5.1. Global Viral Vectors & Plasmid DNA Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion<\/p>\n

5.2. Global Viral Vectors & Plasmid DNA Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion<\/p>\n

Interested to know more about The Business Research Company?<\/strong><\/p>\n

The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology.<\/p>\n

Media Contact<\/span>
Company Name:<\/strong> The Business Research Company<\/a>
Contact Person:<\/strong> Oliver Guirdham
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> +44 20 7193 0708
Address:<\/strong>1st Floor, Anshu Colors Building, Road Number 1 Park View Enclave, Jubilee Hills
City:<\/strong> London
State:<\/strong> Greater London
Country:<\/strong> United Kingdom
Website:<\/strong> https:\/\/www.thebusinessresearchcompany.com\/<\/a><\/p>\n

<\/object>\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

MassBiologics Is One Of The Largest Players In The Viral Vectors & Plasmid DNA Market, According To The Business Research Company\u2019s Viral Vectors & Plasmid DNA Market Global Report 2020-30: COVID-19 Implications And Growth. (Companies Covered: FUJIFILM Diosynth Biotechnologies, FinVector … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[435,405,406,420,404],"tags":[],"class_list":["post-494639","post","type-post","status-publish","format-standard","hentry","category-Europe","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-Science","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/494639","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=494639"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/494639\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=494639"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=494639"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=494639"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}